Manchester Thoracic Oncology Centre, North West Lung Centre, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, UK; Division of Infection, Immunity to Infection and Respiratory Medicine, University of Manchester, Manchester, UK.
Manchester Thoracic Oncology Centre, North West Lung Centre, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, UK.
Lung Cancer. 2022 Nov;173:1-4. doi: 10.1016/j.lungcan.2022.08.017. Epub 2022 Sep 2.
Here we report the prevalence of incidental findings (IF) in the Manchester Lung Health Check pilot, which delivered mobile low-dose CT targeted lung cancer screening. 187 IFs were reported in 158 participants (11.2 % of individuals screened; n = 1,409). 101 IFs in 90 participants (6.4 %) were concerning for extra-pulmonary malignancy. IFs resulted in 118 imaging studies, 20 invasive investigations, and 106 new diagnoses, including 5 malignancies (0.35 %). Clinical management of IFs required 84 specialist reviews (6.0 %), 34 medication changes (2.4 %) and 10 interventional treatments (0.71 %). Lung cancer screening detects clinically relevant IFs but further research is needed to better understand the potential benefits and harms of such findings to participants.
我们在此报告曼彻斯特肺癌筛查试点中偶然发现的(IF)的发生率,该试点提供了移动的低剂量 CT 靶向肺癌筛查。在 158 名参与者(筛查人数的 11.2%,n=1409)中报告了 187 个 IF。在 90 名参与者(6.4%)中,有 101 个 IF 令人担忧可能患有肺外恶性肿瘤。IF 导致了 118 项影像学研究、20 项侵入性调查和 106 个新诊断,包括 5 例恶性肿瘤(0.35%)。IF 的临床管理需要 84 次专家审查(6.0%)、34 次药物改变(2.4%)和 10 次介入治疗(0.71%)。肺癌筛查可以检测到有临床意义的 IF,但需要进一步的研究来更好地了解这些发现对参与者的潜在益处和危害。